| Dr Wenping Li, MD | |
|
3300 Gallows Rd, Falls Church, VA 22042-3300 | |
| (703) 776-4001 | |
| (703) 776-7113 |
| Full Name | Dr Wenping Li |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 31 Years |
| Location | 3300 Gallows Rd, Falls Church, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417111238 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
| Inova Alexandria Hospital | Alexandria, VA | Hospital |
| Inova Loudoun Hospital | Leesburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services - Pathology | 8426241647 | 34 |
| Inova Health Care Services - Pathology | 8426241647 | 34 |
News Archive
Emergent BioSolutions Inc. today announced that the U.S. government has indicated its intention to award Emergent a sole source contract (RFP-2011-N-13414) for the purchase of 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) for inclusion in the Strategic National Stockpile (SNS) over a 5 year period.
Texas Biomedical Research Institute and Wisconsin-based non-profit Take Off Pounds Sensibly are establishing the new TOPS® Nutrition and Obesity Research Center with the goal of conducting research into the causes, health risks and treatment of human obesity. Studies at the Center will focus on the role of genetic predisposition to metabolic changes, nutritional preferences, appetite regulation, food intake and choice and incidence of obesity-related illnesses.
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.
ChanTest, the leading CRO expert in ion channels and nonclinical cardiac safety testing, announces funding of a Phase II SBIR grant. ChanTest will use the grant from the National Heart Lung & Blood Institute to optimize drug safety and discovery assays using stem cell-derived human cardiomyocytes
Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that new data on Vectra DA will be featured at the 2014 American College of Rheumatology Annual Meeting, Nov. 15-19, 2014, in Boston, Massachusetts.
› Verified 4 days ago
| Entity Name | Inova Health Care Services - Pathology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427369578 PECOS PAC ID: 8426241647 Enrollment ID: O20101020001195 |
News Archive
Emergent BioSolutions Inc. today announced that the U.S. government has indicated its intention to award Emergent a sole source contract (RFP-2011-N-13414) for the purchase of 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) for inclusion in the Strategic National Stockpile (SNS) over a 5 year period.
Texas Biomedical Research Institute and Wisconsin-based non-profit Take Off Pounds Sensibly are establishing the new TOPS® Nutrition and Obesity Research Center with the goal of conducting research into the causes, health risks and treatment of human obesity. Studies at the Center will focus on the role of genetic predisposition to metabolic changes, nutritional preferences, appetite regulation, food intake and choice and incidence of obesity-related illnesses.
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.
ChanTest, the leading CRO expert in ion channels and nonclinical cardiac safety testing, announces funding of a Phase II SBIR grant. ChanTest will use the grant from the National Heart Lung & Blood Institute to optimize drug safety and discovery assays using stem cell-derived human cardiomyocytes
Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that new data on Vectra DA will be featured at the 2014 American College of Rheumatology Annual Meeting, Nov. 15-19, 2014, in Boston, Massachusetts.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wenping Li, MD 3300 Gallows Rd, Falls Church, VA 22042-3300 Ph: (703) 776-4001 | Dr Wenping Li, MD 3300 Gallows Rd, Falls Church, VA 22042-3300 Ph: (703) 776-4001 |
News Archive
Emergent BioSolutions Inc. today announced that the U.S. government has indicated its intention to award Emergent a sole source contract (RFP-2011-N-13414) for the purchase of 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) for inclusion in the Strategic National Stockpile (SNS) over a 5 year period.
Texas Biomedical Research Institute and Wisconsin-based non-profit Take Off Pounds Sensibly are establishing the new TOPS® Nutrition and Obesity Research Center with the goal of conducting research into the causes, health risks and treatment of human obesity. Studies at the Center will focus on the role of genetic predisposition to metabolic changes, nutritional preferences, appetite regulation, food intake and choice and incidence of obesity-related illnesses.
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.
ChanTest, the leading CRO expert in ion channels and nonclinical cardiac safety testing, announces funding of a Phase II SBIR grant. ChanTest will use the grant from the National Heart Lung & Blood Institute to optimize drug safety and discovery assays using stem cell-derived human cardiomyocytes
Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that new data on Vectra DA will be featured at the 2014 American College of Rheumatology Annual Meeting, Nov. 15-19, 2014, in Boston, Massachusetts.
› Verified 4 days ago
Tuyethoa N. Vinh, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-3623 | |
Philip Andrew Branton, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3428 | |
Dr. Abdus Salam, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Road, Falls Church, VA 22042 Phone: 703-776-1110 | |
Roy R Zhang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Dr. Kamyar Khazaeian, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Michelle D Xia, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-4001 Fax: 703-776-7113 | |
Lucia Pastore, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-2746 |